LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdo
Go back to LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdo| (NASDAQ: LENZ) | Delayed: 6.15 -0.19 (3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.34 | 52 Week High | $ | |||
| Open | $6.38 | 52 Week Low | $ | |||
| Day High | $6.55 | P/E | N/A | |||
| Day Low | $5.84 | EPS | $ | |||
| Volume | 1,125,461 | |||||
